ARLINGTON, Va., Aug. 13 /PRNewswire/ -- According to new research from BioInformatics, LLC (http://www.gene2drug.com) -- the leading market research and consulting firm serving the life science industry -- service providers in the life science industry must innovate to find new ways to demonstrate customer value. As offerings become more diverse, including multi-vendor, original equipment manufacturer (OEM), in-house and a combination of all three, vendors must respond to customers' increasing demand for choices. In its latest report, "Instrumentation Service Contracts: Opportunities for Differentiation," BioInformatics, LLC explores optimal ways to balance risk, quality and costs of service and/or maintenance contracts.
"Navigating the complex terrain of service and/or maintenance contracts poses new challenges for life science suppliers," observed Tamara Zemlo, Ph.D., Director of Syndicated Research and Analysis at BioInformatics. "Instruments have become more sophisticated and customers are more demanding." According to Dr. Zemlo, structuring contracts in a way that responds to the unique needs of each client is the key to winning in this increasingly competitive landscape.
This report provides an in-depth market overview and competitive analysis of the most common types of contracts offered in the life sciences market. While almost one-half of maintenance and/or service contracts are with the OEM, customers are more frequently turning to alternative suppliers. According to the life scientists surveyed for this report, in addition to dependability, customers expect personalized service and maximum flexibility as well.
The report has a number of significant findings for scientific and lab
equipment suppliers. 49% of maintenance and/or service contracts are for a
single-year duration. 36% of scientists who are disappointed with service
would give contract providers a second chance and
|SOURCE BioInformatics, LLC|
Copyright©2008 PR Newswire.
All rights reserved